Skip to content

Nurse-led intervention to improve medication adherence in older adults with hypertension in primary care

Efficacy of the implementation of a nurse-led adherence protocol in older patients with hypertension in primary care centres

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN35559821
Enrollment
280
Registered
2026-01-02
Start date
2026-02-09
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System

Interventions

Randomisation will be performed at the level of the nursing professional (cluster randomisation). Within each participating primary care centre, nurses will be randomly allocated in a 1:1 ratio to eit
however, outcome assessment will be performed using standardised instruments and routinely collected clinical data. A nurse-led mixed educational and behavioural intervention delivered in primary car

Sponsors

Department of Health of the Government of Navarra (Spain)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 120 Years

Inclusion criteria

Inclusion criteria: Current key inclusion criteria as of 29/05/2026: 1. Age =60 years 2. Diagnosis of arterial hypertension 3. Prescribed antihypertensive medication 4. Non-adherence according to the MMAS-4 standardized scoring method 5. At least one primary care visit in the previous year 6. Written informed consent _____ Previous key inclusion criteria: 1. Age =60 years 2. Diagnosis of arterial hypertension 3. Prescribed antihypertensive medication 4. Non-adherence (Morisky–Green score =1) 5. At least one primary care visit in the previous year 6. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Institutionalised patients 2. Life expectancy <12 months 3. Cognitive or physical conditions preventing participation

Design outcomes

Primary

MeasureTime frame
Previous primary outcome(s): 1. Medication adherence measured using Morisky–Green questionnaire at baseline, 6 months and 12 months

Secondary

MeasureTime frame
These outcomes (blood pressure control, health-related quality of life, cardiovascular-related emergency department visits and hospital admissions, and medication adherence based on pharmacy refill data) will also be analysed to evaluate whether the effectiveness of the intervention differs by sex/gender (effect modification analysis).

Countries

Spain

Contacts

Public ContactAlcibiades Segundo Diaz Vera
as.diaz.vera@navarra.es+34 (0)617321081

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 11, 2026